Skip to content

Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway

Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01684059
Enrollment
60
Registered
2012-09-12
Start date
2011-07-31
Completion date
2012-07-31
Last updated
2012-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenozoospermia

Brief summary

The ability of spermatozoa to produce reactive oxygen species (ROS) has been respected since the 1940's. Oxidative stress limits the functional competence of mammalian spermatozoa via lipid peroxidation, the induction of oxidative DNA damage and the formation of protein adducts. Nitric oxide (NO) is a free radical generated from the oxidation of L-arginine to L-citrulline by reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent NO synthases. Several studies suggest that the overproduction of this free radical and the subsequent excessive exposure to oxidative conditions have a potential pathogenetic implication, which due to the reduction of sperm motility. The present study was conducted to study the effect of Zn supplementation on the levels of NO synthase and arginase in semen of patients with asthenozoospmia.

Detailed description

Previous studies suggest that high concentrations of NO play an injurious consequence on spermatozoa kinetic characteristics. These studies reported that NO may react with superoxide or hydrogen peroxide, resulting in the production of peroxinitrite, hydroxyl radical, or singlet oxygen, which cause oxidation of sperm membrane lipids and thiol proteins. NO also may inhibit cellular respiration by nitro-sylation of heme in mitochondrial enzymes, aconitase, and glyceraldehyde phosphate dehydrogenase, leading to a reduction of adenosine triphosphate and that is due to loss of motility of spermatozoa.

Interventions

DIETARY_SUPPLEMENTzinc sulfate

every participant took two capsules of zinc sulfate per day for three months (each one 220mg)

Sponsors

Ministry of Health, Iraq
CollaboratorNETWORK
Babylon University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
27 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* the presence of asthenozoospermia in the semen sample.

Exclusion criteria

* the absence of endocrinopathy, * varicocele, and * female factor infertility. Smokers and alcoholic men were excluded from the study because of their recognized high seminal ROS levels and decreased antioxidant levels

Design outcomes

Primary

MeasureTime frame
Nitric oxide synthase activityat the end of three months

Secondary

MeasureTime frame
Arginase activityat the end of three months

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026